002581 Shandong Sinobioway Biomedicine
- 12.62
- +0.12+0.96%
About Shandong Sinobioway Biomedicine Company
The company is a foreign-invested company limited by Zibo Wanchang Technology Development Co., Ltd. established on November 16, 2009 (now changed to a domestic enterprise) with the approval of the Shandong Provincial Department of Commerce with the approval of Yelu Business Foreign Investors [2009] No. 289. The company's stock was listed and traded on the SME board of the Shenzhen Stock Exchange on May 20, 2011. The company's business segments include biomedical segments such as interferons, nerve growth factors, vaccines and pharmaceutical intermediates. The company has important products including nerve growth factor products, mouse nerve growth factor for injection (trade name: Enjingfu), interferon products, human interferon α2b injections (trade name: amfulon), and human interferon α2b sprays (trade name: tactile). Corporate honors: High-tech Enterprise Certificate; Xiamen Bioengineering Technology Research Center; High-tech Achievements Fair Outstanding Product Award; Xiamen Independent Innovative Seed Enterprise; Fujian Excellent New Product; Fujian Innovative Pilot Enterprise; Green Development Zone, etc.
Company Profile
Company Executives
- Name
- Position
- Salary
- jialin yue
- Chairman, Directors, General Manager, Chairman of the Strategic Decision Committee
- 1.78M
- xiuyuan yu
- Vice Chairman, Directors
- 813.80K
- wenjie yu
- Directors
- 649.90K
- wenjun liu
- Directors, Member of the Remuneration and Assessment Committee, Member of the Strategic Decision Committee
- 1.02M
- ying yue
- Directors
- 16.70K
- guiyuan huang
- Directors, Audit Committee Member, Nomination Committee Members
- 531.00K
- yang liu
- Independent Directors
- --
- yang xia
- Independent Directors, Nomination Committee Members
- 100.00K
- rongfu zhang
- Independent Directors, Chairman of the Remuneration and Assessment Committee, Audit Committee Member
- 100.00K
- jie xiao
- Independent Directors, Chairman of the Nomination Committee, Member of the Remuneration and Assessment Committee, Chairman of the Audit Committee
- 100.00K
- xiaoru shi
- Board Secretary
- --
- chenxi lin
- Securities Affairs Representative
- --
- ying ke
- Chairman of the Supervisory Board, Auditors
- 232.30K
- xueming yan
- Auditors
- 457.60K
- juanxiong xu
- Deputy General Manager
- 1.14M
- yangjun liu
- Chief Financial Officer
- 902.80K
- na yao
- Head of Audit
- --
- long peng
- Employee Supervisors
- --
- hui zhao
- Member of the Strategic Decision Committee, Employee Directors
- 1.16M
Analysis
Price Target
No Data
No Data